
Number of people with ADHD ‘probably isn't increasing that much'
Experts said that while there has been a rise in people being diagnosed with ADHD in the UK, the exact number is 'still probably lower than the best estimates' of the true number who have the condition.
An increase in patients seeking assessments could possibly be down to greater awareness and less stigma, or disruption caused by the Covid-19 pandemic.
Researchers also suggest spending a lot of time online could be creating a 'distracted generation', but that it is too early to draw conclusions.
And while there is a link between social media and ADHD symptoms it is unclear 'what's driving what'.
ADHD assessments are reported to be increasingly in demand, researchers said, which is putting a strain on health and education systems across the world.
People with the neuro-developmental disorder may have trouble concentrating or sitting still, while other symptoms include being easily distracted, forgetfulness, finding it hard to follow instructions or organise time, and making impulsive decisions.
Earlier this month, NHS England estimated for the first time that 2,498,000 people in England may have ADHD, which includes those without a diagnosis.
Of the total, an estimated 741,000 are children and young people aged five to 24.
And more than half a million people (549,000) were waiting for an ADHD assessment at the end of March 2025, up from 416,000 a year earlier, according to figures.
The study, led by King's College London, aimed to update reviews on ADHD prevalence by examining global research from 2020 onwards.
Academics looked at more than 9,000 studies, with 40 from across 17 different countries – one of which included data from 42 countries – included in the final analysis.
Professor Philip Shaw, director of the King's Maudsley Partnership for Children and Young People at KCL's institute of psychiatry, psychology and neuroscience, said: 'It seems that our best evidence suggests that the true rate of ADHD probably isn't increasing that much.
'However, it's absolutely crystal clear that there is an increase in the number of people who are being clinically recognised or diagnosed as having ADHD in the United Kingdom.
'However, I will note that that rate is still probably lower than the best estimates we have of the rate of true ADHD in the population.'
Dr Alex Martin, a lecturer in psychology and pandemic preparedness at KCL's institute of psychiatry, psychology and neuroscience, added: 'What we did find was that ADHD prevalence in adults and children has remained largely stable since 2020.'
She said that some data being published is 'very much out of date', adding: 'This causes problems for healthcare policy makers internationally and means that services which are already under pressure may encounter increased demand without receiving additional support.
According to Prof Shaw, the health service is 'playing catch-up' when it comes to ADHD, which he said could explain 'a marked uptick in the numbers of people seeking assessment'.
Edmund Sonuga-Barke, a professor of developmental psychology, psychiatry and neuroscience at KCL, added there has been 'chronic under-recognition' in the history of ADHD, especially for certain groups and in particular women and girls.
'So part of the increase in diagnosis we've seen over the last 10 or so years is really a resetting or a recalibration, or a catch-up,' he said.
Prof Shaw added: 'When I was at medical school and training as a psychiatrist, there was actually very little recognition of ADHD, particularly in young people and adults.
'Of course, there's both an increased recognition and – very welcome – less stigma around ADHD, which means that people are increasingly coming forward for assessment, and while we're working through that backlog, there are simply going to be long waiting lists.'
Some other possibilities which Prof Shaw described as 'somewhat less likely' include a change in the threshold of how doctors diagnose ADHD and a shift in the understanding of the condition by children and young people.
He added that his 'hunch' is that the 'huge awareness' of ADHD is 'that it's often used as a language of distress'.
'It's sometimes used, I suspect, the way that children and young people are expressing that they are struggling, particularly at school, and need help,' he said
'And of course, when a child is having problems that are impacting their life in a sustained way, they deserve a full mental health assessment.
'Even if the final diagnosis doesn't end up being ADHD, we may often, for example, find that this child is struggling with a problem with mood or anxiety.'
Other societal issues could be driving the increase in assessments, including the disruption caused by the Covid-19 pandemic and the use of social media.
Prof Shaw said: 'Many of the skills of learning that kids have, how to focus, how to plan, how to organise themselves, has completely throw them out the loop for about two or three years, and this may well play a part in the uptick in the awareness and seeking of help for symptoms of inattention in particular.
'Many also point to a possible role for social media and the impacts it might be having on the developing brain.
'Now, for ADHD, there's a great degree of interest in the possibility that what's going on, is that the constant dividing of attention and multitasking online is creating, if you like, a distracted generation.
'We know there's an association between social media use and some symptoms of ADHD, but we don't know what's driving what, we don't know what's the chicken and what's the egg.'
Prof Shaw said he has been 'struck' by some of his group's research findings into how 'variable' ADHD can be.
He suggests ADHD 'is a dynamic challenge that changes with age'.
Prof Sonuga-Barke added: 'I think the discovery that ADHD is a continuous risk dimension and not a fixed, natural category with clear biological boundaries may help explain why diagnostic rates are sensitive to changes in cultural values and beliefs, and clinical practices, and environmental risk exposures.'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Glasgow Times
23 minutes ago
- Glasgow Times
Covid booster warning as Covid NB.1.8.1 cases on the rise
The message comes after health experts also warned of a new COVID-19 variant, with cases of the strain are on the rise around the world. Covid NB.1.8.1 is a variation of the XDV.1.5.1 strain and was first detected back in January 2025. Ifti Khan, superintendent pharmacist at Well Pharmacy, urged those eligible to book as soon as possible and get the booster while it is still available. He said: 'Covid will most likely rise coming into the end of spring and into summer as people mix with friends and family more often. 'We know from previous boosters that they are effective in making sure that patients' symptoms are not as severe as they might have been without so I would urge patients to pop into their local Well Pharmacy store and get their jab. 'Patients have just over two weeks as the spring booster programme ends on June 17 so it would be my hope that those who can get a jab, opt to do so before enjoying socialising during summer.' Mr Khan warned that at this time of year, some people may believe they have hay fever as early symptoms of Covid include a runny or blocked nose or a sore throat. Covid tests can be obtained at any Well Pharmacy. World Health Organisation monitoring COVID NB.1.8.1 The WHO has placed the Covid NB.1.8.1 "under monitoring" due to the rise in cases worldwide. It is one of six COVID-19 variants currently being monitored. The new 'Strategic and operational plan for coronavirus disease threat management: at a glance' sets out the global framework for supporting Member States in the sustained, integrated, evidence-based management of coronavirus disease threats, including #COVID19, MERS, and… — World Health Organization (WHO) (@WHO) May 28, 2025 However, the WHO stated that the risk posed by the new variant was "low," and that approved COVID-19 vaccines are expected to be effective against it. The world health experts, in a recent risk evaluation, said: "Despite a concurrent increase in cases and hospitalisations in some countries where NB.1.8.1 is widespread, current data do not indicate that this variant leads to more severe illness than other variants in circulation. The WHO added: "The available evidence on NB.1.8.1 does not suggest additional public health risks relative to the other currently circulating Omicron descendent lineages." Where has Covid NB.1.8.1 been detected? COVID NB.1.8.1 has already been detected in 22 countries. These include the likes of Australia, China, Hong Kong, Thailand and the US, according to The Independent. The coming COVID-19 Winter Surge in Australia will show the world where we are actually headed is happening in South-Eats Asia and East Asia are just the 'preludes'...watch how NB.1.8.1 spawns are evolving including PQ.1, PQ.2 and even sub-lineages like PE.1. — Thailand Medical News (@ThailandMedicaX) June 4, 2025 COVID NB.1.8.1 in the UK Cases of the NB.1.8.1 variant have also been confirmed in Northern Ireland, Wales, and "popular British tourist hotspots", the news outlet added.


Metro
32 minutes ago
- Metro
Fears of measles 'surge' in UK when unvaccinated kids return from summer holiday
The UK is at risk of a 'surge' in measles cases in the coming months due to a decline in vaccine uptake, officials have warned. Unvaccinated children are expected to pick up the virus on summer trips abroad, with a number of popular destinations having seen 'large' outbreaks this year, the UK Health Security Agency (UKHSA) said. France, Italy, Spain and Germany are among those suffering such outbreaks in Europe, which reported 127,350 cases overall last year. That figure was double the number of cases in 2023 and the highest recorded since 1997. 'Measles cases are picking up again in England and outbreaks are happening in Europe and many countries with close links to the UK,' Dr Vanessa Saliba, Consultant Epidemiologist at the UK Health Security Agency, said. Nigeria, Pakistan, India, Romania and Thailand currently have among the highest number of measles cases in the world, according to the World Health Organisation. The UKHSA said the resurgence of measles is a 'global' problem linked to 'declines in MMR vaccine uptake observed over the last decade, exacerbated by the COVID-19 pandemic'. More than 17% of children in England have not had a two-dose MMR vaccine, which is needed for full protection. That figure rises to nearly 28% in London, which has reported almost half of all cases in the past four weeks. There have been 420 lab-confirmed cases in England so far this year, of which 109 were in April and 86 in May. 'Cases have predominantly been in unvaccinated children aged 10 years and under,' officials said, 'but there are also cases being reported in young people and adults'. After London, the biggest hotspots currently are the North West (25% of cases in the past four weeks) and the West Midlands (11%). Children do not have full protection if they received their first dose after their first birthday but were not taken to get the second (given between three-and-a-half and five years old). Full protection can be given at higher ages by taking two doses at least one month apart, the NHS says. The most contagious virus known to humans, measles can rapidly trigger large outbreaks as each infected individual can transmit the disease to another 18 on average. It typically causes cold-like symptoms at first before triggering a widespread, blotchy rash across the body. In some cases it can suppress the immune system, making the patient vulnerable to other viruses like pneumonia, which can be deadly in children. Dr Saliba continued: 'It's essential that everyone, particularly parents of young children, check all family members are up to date with 2 MMR doses, especially if you are travelling this summer for holidays or visiting family. 'Measles spreads very easily and can be a nasty disease, leading to complications like ear and chest infections and inflammation of the brain with some children tragically ending up in hospital and suffering life-long consequences. Nobody wants this for their child and it's not something you want to experience when away on holiday. 'The MMR vaccine is the best way to protect yourself and your family from measles. Babies under the age of 1 and some people who have weakened immune systems can't have the vaccine and are at risk of more serious complications if they get measles. They rely on the rest of us getting the vaccine to protect them. 'It is never too late to catch up, if you're not sure if any of your family are up to date, check their Red Book or contact your GP practice. Don't put it off and regret it later.' Get in touch with our news team by emailing us at webnews@ For more stories like this, check our news page. MORE: Urgent recall for 15,000 pounds of beef and meat jerky over allergy fears MORE: Urgent health alert for ham croquettes in the US over allergy fears MORE: FDA tomato recall elevated to highest level due to salmonella risk


Wales Online
32 minutes ago
- Wales Online
Doctors explain symptoms of UK's new Nimbus Covid and why it's different
Doctors explain symptoms of UK's new Nimbus Covid and why it's different The UKHSA has confirmed the subvariant mutation has now reached the UK People describe having a very sore throat with the new variant For many of us, Covid-19 feels like a chapter we've closed – along with the days of PCR tests, mask mandates and daily case updates. But while life may feel back to normal, the virus hasn't completely vanished. In fact, new variants continue to quietly circulate. One of the latest to appear on the radar is NB.1.8.1 – a name that you may have seen pop up in headlines and on social media feeds this week. This newly emerging sub-variant hasn't triggered widespread concern, but it has caught the attention of scientists and health officials. The UK Health Security Agency (UKHSA) announced this week that NB.1.8.1 has so far only been detected in small numbers within the UK, but added that international data indicates that the sub-variant is steadily accounting for a growing share of global Covid-19 cases. We consulted some GPs to find out exactly what sets the NB.1.8.1 Covid variant apart from the rest. Is it more contagious, more immune-evasive, or simply another step in Covid's slow evolution? Here's what they know so far… What is the new NB.1.8.1 Covid variant and where has it come from? 'The NB.1.8.1 variant, also referred to as Nimbus, is a new strain of the Covid-19 virus that has emerged due to mutations in its genetic material,' says Dr Naveed Asif, GP at The London General Practice. It's a sub-variant of Omicron, says Dr Chun Tang, GP at Pall Mall Medical. Article continues below 'Variants like this pop up when the virus mutates, which is normal for viruses, especially ones that spread widely,' explains Tang. 'NB.1.8.1 was first picked up in early 2025 and has since been detected in several countries, including the UK, China and US. It's got some new mutations that scientists are keeping a close eye on.' How is Nimbus different from previous variants? 'NB.1.8.1 isn't too different from the Omicron variant, but it does have some tweaks to its spike protein, which might make it spread a bit more easily or slip past some of our existing immunity,' says Tang. 'That said, early signs suggest it doesn't seem to cause more serious illness, but of course, we're still learning more about it.' However, Nimbus does appear to be more transmissible than previous variants, with notable increases reported in India, Hong Kong, Singapore, and Thailand, notes Asif. 'Its spread has been identified in around 22 countries,' says Asif. 'The World Health Organization (WHO) assesses the additional risk to the global public as currently low, and existing Covid-19 vaccines are considered effective in preventing severe disease.' How is Nimbus spreading? 'It's spreading in the usual way, person to person, mainly through respiratory droplets when people cough, sneeze or even just talk closely,' says Tang. 'Like other variants, it can hang around in the air in poorly ventilated spaces.' What Nimbus Covid symptoms should people look out for? 'Common symptoms of the NB.1.8.1 variant include severe sore throat (described as a 'razor blade sensation'), fatigue, mild cough, fever, muscle aches and congestion,' says Asif. 'However, symptoms can vary widely so vigilance is key.' What are the Nimbus treatment options? 'Treatment for Nimbus generally aligns with that for other Covid-19 variants,' says Asif. 'Most individuals will recover at home with rest, hydration, and over-the-counter medications for symptom management. 'For those with severe symptoms or high-risk complications, antiviral medications or monoclonal antibody treatments may be recommended. Always consult your GP for personalised advice.' How can you avoid getting the Nimbus variant? 'Make sure everyone's up to date with their Covid-19 jabs, especially boosters,' recommends Tang. 'Wash your hands regularly, keep rooms well ventilated, and consider popping a mask on in busy places or if you're around people who are more vulnerable. Article continues below 'If someone in the house is feeling poorly, try to keep some distance and clean shared surfaces regularly.' When should you see a GP about Covid? 'Seek medical advice if you experience Covid-19 symptoms, especially if they worsen or if you have underlying health conditions that increase your risk,' advises Asif. 'Additionally, consult your GP if you've been in close contact with someone who has tested positive for the NB.1.8.1 variant or if you have health concerns.'